• Study on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis

    Not recruiting

    2 1
    Austria Belgium France Germany Italy Latvia +2
  • Study Comparing Abatacept and Tocilizumab for Adults with Rheumatoid Arthritis Not Responding to Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • Study on Ketamine and Sodium Chloride for Reducing Morphine Use in Patients with Severe Trauma

    Not recruiting

    3 1 1
    France
  • Study on the Effects of Omalizumab on Carotid Artery Stenosis in Patients Undergoing Carotid Endarterectomy

    Not recruiting

    3 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Safety and Effectiveness of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory B-cell Non-Hodgkin’s Lymphoma

    Not recruiting

    2 1 1 1
    Belgium Czechia Denmark Finland France Italy +2
  • Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Belgium Finland France Germany Ireland +5
  • Study on Apalutamide with Radiotherapy and Hormone Therapy for High-Risk Prostate Cancer Patients with Rising PSA After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Croatia Czechia France Germany Hungary +7
  • Study of cangrelor with mechanical thrombectomy in patients with acute ischemic stroke selected by perfusion imaging

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • Study on Fenebrutinib for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    Croatia Czechia Slovakia

powered by